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ABSTRACT  
Objective: The aim of study was to evaluate acute toxicity and antidiabetic activity of methanolic extract of Schrebera swietenoides roots in 
streptozotocin induced diabetic rats.  
Methods: Acute toxicity of the methanolic extracts of Schrebera swietenoides roots was studied in Wistar albino rats at a dose level upto 2 g/kg b.w. 
The animals were also closely examined for signs of intoxication, lethargy, behavioral modification and morbidity. The plant was evaluated for 
antidiabetic activity against Streptozotocin 
Results: The extracts did not produce any toxic signs during the observation period for 24 h. The oral administration of 400 mg/kg b. w of 
methanolic extract of Schrebera swietenoides roots showed significant (P<0.05) decrease in blood glucose levels up to 18
induced diabetic model in different concentrations of 100,200 and 400 mg/kg body weight. The mean 
and percent blood glucose reduction levels were calculated and comparable with the standard drug, glibenclamide (0.45 mg/kg b. w). 
th h, more significant 
(P<0.01) decrease in blood glucose levels at 4th and 12th h and highly significant (P<0.001) decrease in blood glucose levels at 8th
Conclusions: From the studies it is concluded that, the methanolic extract of Schrebera swietenoides roots is suitable to prepare ayurvedic 
formulations for the treatment of diabetes. 
 h respectively. 
Keywords: Schrebera swietenoides, Glibenclamide, Streptozotocin, Antidiabetic activity. 
 
INTRODUCTION 
Diabetes mellitus is a chronic metabolic disorder occurs with the 
impairment in carbohydrate metabolism due to release and absolute 
depletion of insulin. It is characterized by the appearance of higher 
concentration of glucose in blood commonly known as 
hyperglycemia, owing to reduced secretion of insulin from the 
pancreas and also tissue insensitivity to insulin. There is an 
increasing demand in use of natural products for treating 
antidiabetic activity due to the side effects associated with the use of 
synthetic drugs [1-3].  
Schrebera swietenoides Roxb. (Oleaceae) is an important medicinal 
plant used in the treatment of leprosy, diabetes and hepatic disorders 
by ethnic people. Traditionally, the root paste has been applied on the 
throat and chest to relieve nasal obstruction of respiratory tract [4, 5]. 
The plant has been reported to possess in vitro inhibitory activity of 
intestinal alpha glucosidase enzyme maltase and also antioxidant 
activity [6, 7]. The aim of the study was to conduct acute toxicity 
studies and also antidiabetic activity of this plant as it is used in 
diabetic conditions by rural people and antidiabetic activity of this 
plant has not yet scientifically proven. 
MATERIALS AND METHODS 
Collection of plant material 
The plant, Schrebera swietenoides, was collected from Tirupati in the 
month of September and was authenticated by Prof. M. Venkaiah, 
Department of Botany, Andhra University. The specimen was 
deposited in the herbarium with Voucher specimen number 
(AU/SS/01/11786).  
Preparation of plant extracts 
Shade dried roots of the plant were made into powder in a Wiley 
mill and extracted in a soxhlet apparatus with methanol(Merck, 
India) for 6 h and concentrated to dryness in a rotary evaporator 
which resulted methanolic extract (34.28 g). The resultant 
methanolic extract was suspended in 1% Sodium CMC and 
administered at a different dose levels of 100, 200 and 400 mg/kg. 
Animals 
For this study Wistar albino rats of either sex (150-200 g) were 
maintained under controlled conditions. The rats were allowed to 
take standard laboratory feed and water ad libitum. The 
experimental protocol was approved by the institutional animal 
ethics committee of Andhra University, Vishakhapatnam, which was 
registered with the Committee for the purpose of control and 
supervision of experiments on animal (CPCSEA), Govt. Of india 
(registration no.516/01/A/CPCSEA). 
Acute toxicity studies 
Toxicity studies were conducted as per internationally accepted 
protocol drawn under OECD guidelines in Wistar albino rats at a 
dose level of extracts up to 2 g/kg b.w. The toxic effect of the 
methanolic extracts of Schrebera swietenoides roots were studied at 
a dose level upto 2 g/kg b.w. The animals were also closely 
examined for signs of intoxication, lethargy, behavioral modification 
and morbidity [8, 9]. 
Design of experiment 
In this experiment, 30 rats were used which were randomly 
divided into 5 groups of 6 animals each. The different doses of 
extracts were administered orally to the STZ induced diabetic rats. 
All the extracts were suspended in 1% sodium CMC suspension. In 
these 5 groups, group 1 served control as they received orally 1% 
Sodium CMC suspension only. Group 2 was administered with a 
standard drug Glibenclamide, (0.45 mg/kg b. w). Group 3,4 and 5 
were treated with methanolic extracts of Schrebera swietenoides 
roots at doses of 100, 200 and 400 mg/kg b.w. The drug treatment 
was given to the animals and was fasted for 12 h before estimating 
the blood glucose level. 
Induction of diabetes 
Diabetes was induced by a single intraperitonial dose of 60 mg/kg of b. 
w of streptozotocin (STZ) dissolved in 0.1M fresh cold citrate buffer 
(pH 4.5) into 12 h fasted rats. On third day of the STZ injection of the 
rats, the blood samples were taken from the retro orbital plexus of the 
rats for the estimation of blood glucose levels by using the auto 
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analyzer. Rats with diabetes having hyperglycemia (i.e. with blood 
glucose to 185 to 460 mg/dl) were taken for the experiment [10-12]. 
Collection of blood samples and serum glucose estimation 
The blood samples (0.5 ml) were collected for every time intervals of 
0, 2, 4, 8, 12, 18, and 24th h in 1 ml Eppendorf’s tubes. Serum was 
separated by centrifuging at 3000 rpm for 10 min. 30 µl of serum 
sample and 3 ml of working glucose reagent were taken in to a dry 
and clean test tube and incubated for 10 min at 37o
The values were expressed as mean±SEM. The data were subjected 
to the analysis of variance (one way ANOVA) to determine the 
significance of changes followed by students “t”-test [16-18]. The 
statistical significance of difference between two independent 
groups was calculated for the determination of blood glucose levels. 
C. The pink color 
developed was measured by using an auto analyzer [13-15].  
Statistical analysis 
RESULTS 
The extracts did not produce any toxic signs during the observation 
period for 24 h in any of the rats they were tested. Hence it was 
concluded that extracts are safe upto 2000 mg/kg and beneficial for 
assessment of antidiabetic activity. 
The mean blood glucose levels of control and drug treated animals 
after oral administration of different doses (100, 200 and 400 mg/kg 
b. w) of methanolic extract of Schrebera swietenoides roots at 
various time intervals (0, 2, 4, 8, 12, 18 and 24 h) were shown in 
table 1. The statistical significance of a decrease in blood glucose 
levels was calculated with respect to initial blood glucose levels. 
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Each value is expressed as mean±S. E. M.(n = 6). *P<0.05 significant decrease as compared to Zero h of standard drug glibenclamide. **P<0.01 More 
significant decrease as compared to zero h. ***
 
The blood glucose levels of diabetic rats treated with Glibenclamide 
(0.45 mg/kg b. w) showed significant (P<0.05) decrease in blood 
glucose levels at 8 &12
P<0.001 Highly significant decrease as compared to zero h. 
th h, more significant (P<0.01) decrease in 
blood glucose levels at 2nd hr and highly significant (P<0.001) 
decrease in blood glucose levels at 4th h.  
Administration of 100 mg/kg b. w of plant crude drug produced no 
significant (P>0.05) decrease in blood glucose levels at all the time 
intervals. However, administration of 200 mg/kg b. w of methanolic 
extract of Schrebera swietenoides roots produced no significant (P>0.05) 
decrease in blood glucose levels up to 4thh after oral administration. 
However, it showed significant (P<0.05) decrease in blood glucose levels 
at 8th and 18th h respectively after the oral administration of the extract. 
It also showed more significant (P<0.01) decrease in blood glucose levels 
at 12th
The oral administration of 400 mg/kg b. w of methanolic extract of 
Schrebera swietenoides roots showed significant (P<0.05) decrease 
in blood glucose levels up to 18
 h after the administration of the extract.  
th h, more significant (P<0.01) 
decrease in blood glucose levels at 4th and 12th h and highly 
significant (P<0.001) decrease in blood glucose levels at 8th h 
respectively. The mean blood glucose levels were 348.14±6.11, 
290.61±9.80, 220.56±9.61, 283.43±9.11 and 297.52±11.65 mg/dl at 
0, 4, 8, 12 and 18th
The percent decrease in blood glucose levels after the oral 
administration of different doses (100, 200 and 400 mg/kg b. w) 
of methanolic extract of Schrebera swietenoides roots was shown 
in table 2. The administration of standard drug Glibenclamide 
showed 25.47±4.23 %, 42.41±2.94 %, 21.65±5.62 % and 
13.81±3.41 % reduction in blood glucose levels at 2, 4, 8 and 12 
h respectively. The percent decrease in blood glucose level at 
24
 h respectively after the administration of 400 
mg/kg b. w of methanolic extract of Schrebera swietenoides roots.  
th
  
 h after the administration of Glibenclamide was not 
significant (P>0.05). 
Table 2: Effect of methanol extract of Schrebera swietenoides roots on percent decrease blood glucose levels in STZ induced diabetic rats 
Group (n=6) Treatment mg/kg b.w. Time in hours 
2 4 8 12 18 24 
1 Control 2.30±2.02 2.48±2.83 2.90±2.61 4.54±2.92 2.91±2.55 3.29±2.34 
2 Glibenclamide 
(0.45 mg/kg b. w) 
25.47±4.23 42.41±2.94** 21.65±5.62*** 13.81±3.41** 7.59±4.60 ** 4.87±4.18 
3 SS 100 4.37±1.60 6.34±1.21* 6.8±2.8 ** 6.15±3.34 6.69±3.34 6.93±3.04 
4 SS 200 3.52±1.19 10.62±2.16* 18.45±3.73** 20.5±4.18** 17.28±4.57** 9.74±5.05 ** 
5 SS 400 7.32±3.24 16.39±3.28 36.46±3.35** 18.46±2.95*** 14.37±3.82** 10.13±3.68* * 
Each value is expressed as mean±S. E. M.(n = 6).*P<0.05 significant decrease as compared to Zero h of standard drug glibenclamide. **P<0.01 More 
significant decrease as compared to zero h. ***
 
P<0.001 Highly significant decrease as compared to zero h. 
Administration of 400 mg/kg b. w of methanolic extract of Schrebera 
swietenoides roots produced significant (P<0.05) decrease in blood 
glucose level at 18 and 24th h, more significant (P<0.01) decrease in 
blood glucose levels at 4 and 12th h and highly significant (P<0.001) 
decrease in blood glucose levels at 8th
DISCUSSION  
 h. Administration of 400 
mg/kg b. w of methanolic extract of Schrebera swietenoides roots 
showed 16.39±3.28%, 36.46±3.35%, 18.46±2.95%, 14.37±3.82% 
and 10.13±3.68% reduction in blood glucose levels at 4, 8, 12, 18 
and 24 h respectively.  
Streptozotocin is one of the most toxic chemical selectively destroy 
the pancreatic insulin secreting β cells by causing diabetes in 
rats[19]. The present study was designed for antidiabetic activity of 
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root extract of Schrebera swietenoides in Streptozotocin induced 
diabetic rats. In this study,damage of pancreas in streptazotocin 
treated diabetic control mice and regeneration of islets of 
Langerhans by glibenclamide was observed. The activity of plant 
extract on the activity of pancreatic beta cells might be attributed to 
the increase in the inhibitory effect against insulinase enzyme, 
increase of the insulin sensitivity. The hypoglycemic effect by 
methanolic extracts of Schrebera swietenoides may be assigned due 
to the regeneration of islet of Langerhans which may confirm the 
efficiency of the given extract in the management of diabetes [20]. 
The lowest blood glucose levels were observed at 12th and 8th h after 
oral administration of 200 and 400 mg/kg b. w of methanolic extract 
of Schrebera swietenoides respectively. It also showed antidiabetic 
activity in a dose dependent manner in STZ induced diabetic rats 
and proceeded with the duration of treatment. Methanol extract 
showed the presence of flavanoids, saponins, phenolic compounds 
and tannins. It is reported that flavanoid constitute the biological 
active principle of most medicinal plants with hypoglycemic and 
anti-diabetic properties. Our study presents significant antidiabetic 
activity of the methanolic leaf extract of Schrebera swietenoides 
1. Reshmi CR, Aneez fathima, Sinilal B, Latha MS. Antidiabetic 
effect of a herbal drug in alloxan diabetic rats. Indian Drugs 
2001;38:319-22. 
for 
its principle constituent flavanoids.  
CONCLUSION 
Methanolic extract of roots the of Schrebera swietenoides exhibited 
prominent antidiabetic activity at different doses which reveals that 
the plant in extract form is used as one of the ingredient to design 
the ayurvedic formulation for the treatment of diabetes.  
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